Related references
Note: Only part of the references are listed.Microbiota derived short chain fatty acids promote histone crotonylation in the colon through histone deacetylases
Rachel Fellows et al.
NATURE COMMUNICATIONS (2018)
Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytes
Chiara Angiolilli et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Formation of propionate and butyrate by the human colonic microbiota
Petra Louis et al.
ENVIRONMENTAL MICROBIOLOGY (2017)
Interplay between diet, gut microbiota, epigenetic events, and colorectal cancer
Scott J. Bultman
MOLECULAR NUTRITION & FOOD RESEARCH (2017)
Gas chromatography - mass spectrometry data processing made easy
Lea G. Johnsen et al.
JOURNAL OF CHROMATOGRAPHY A (2017)
Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study
Tomomi Minato et al.
PLOS ONE (2017)
Can intestinal microbiota be associated with non-intestinal cancers?
Camille Jacqueline et al.
SCIENTIFIC REPORTS (2017)
Inhibiting Histone Deacetylase 2 (HDAC2) Promotes Functional Recovery From Stroke
Ying Tang et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
New evidences on the altered gut microbiota in autism spectrum disorders
Francesco Strati et al.
MICROBIOME (2017)
Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome
Ludovic Giloteaux et al.
MICROBIOME (2016)
Gut microbiota, metabolites and host immunity
Michelle G. Rooks et al.
NATURE REVIEWS IMMUNOLOGY (2016)
The gut microbiota and Type 1 Diabetes
Elke Guelden et al.
CLINICAL IMMUNOLOGY (2015)
Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
Kristoffer Forslund et al.
NATURE (2015)
Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases
C. Felice et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters
Sachiko Miyake et al.
PLOS ONE (2015)
New and emerging HDAC inhibitors for cancer treatment
Alison C. West et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
The histone deacetylase Hdac1 regulates inflammatory signalling in intestinal epithelial cells
Alexis Gonneaud et al.
JOURNAL OF INFLAMMATION-LONDON (2014)
Gut Microbes and the Brain: Paradigm Shift in Neuroscience
Emeran A. Mayer et al.
JOURNAL OF NEUROSCIENCE (2014)
The gut microbiota influences blood-brain barrier permeability in mice
Viorica Braniste et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Polyamines: Emerging players in bacteria-host interactions
Maria Letizia Di Martino et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2013)
Histone deacetylase 3 coordinates commensal-bacteria-dependent intestinal homeostasis
Theresa Alenghat et al.
NATURE (2013)
Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats
Hui-Lu Zhang et al.
JOURNAL OF HEPATOLOGY (2012)
Valproic acid mediates the synaptic excitatory/inhibitory balance through astrocytes - A preliminary study
Chao-Chuan Wang et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2012)
Thailandepsins are new small molecule class I HDAC inhibitors with potent cytotoxic activity in ovarian cancer cells: a preclinical study of epigenetic ovarian cancer therapy
Andrew J. Wilson et al.
JOURNAL OF OVARIAN RESEARCH (2012)
Butyrate Histone Deacetylase Inhibitors
Kosta Steliou et al.
BIORESEARCH OPEN ACCESS (2012)
Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma
Richard L. Piekarz et al.
BLOOD (2011)
Exogenous Stimuli Maintain Intraepithelial Lymphocytes via Aryl Hydrocarbon Receptor Activation
Ying Li Silvia Innocentin et al.
CELL (2011)
Gut microbiota, probiotics, and vitamin D: Interrelated exposures influencing allergy, asthma, and obesity?
Ngoc P. Ly et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Thailandepsins: Bacterial Products with Potent Histone Deacetylase Inhibitory Activities and Broad-Spectrum Antiproliferative Activities
Cheng Wang et al.
JOURNAL OF NATURAL PRODUCTS (2011)
Epigenetic modifications as therapeutic targets
Theresa K. Kelly et al.
NATURE BIOTECHNOLOGY (2010)
Epigenetic modifications and human disease
Anna Portela et al.
NATURE BIOTECHNOLOGY (2010)
Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
Richard L. Piekarz et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Isoform-selective histone deacetylase inhibitors
Anton V. Bieliauskas et al.
CHEMICAL SOCIETY REVIEWS (2008)
Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders
Ted Abe et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Butyrate and trichostatin A attenuate nuclear factor κB activation and tumor necrosis factor α secretion and increase prostaglandin E2 secretion in human peripheral blood mononuclear cells
Makoto Usami et al.
NUTRITION RESEARCH (2008)
A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2
Qun Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
α-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity
Eirene Kontopoulos et al.
HUMAN MOLECULAR GENETICS (2006)
Histone hyperacetylation is associated with amelioration of experimental colitis in mice
Rainer Glauben et al.
JOURNAL OF IMMUNOLOGY (2006)
Celecoxib and rofecoxib potentiate chronic colitis and premalignant changes in interleukin 10 knockout mice
RAF Hegazi et al.
INFLAMMATORY BOWEL DISEASES (2003)
A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate
T Tanaka et al.
CANCER SCIENCE (2003)
Share Paper
